Brief: Pardes Biosciences reports Q2 results

Pardes Biosciences

15/08/2022 13:27

Aug 15 (Reuters) - Pardes Biosciences Inc  PRDS.O :
    * PARDES BIOSCIENCES REPORTS SECOND QUARTER 2022 FINANCIAL
RESULTS
AND PROVIDES BUSINESS UPDATE
    * PARDES BIOSCIENCES INC - CASH AND CASH EQUIVALENTS AS OF
JUNE
30, 2022, WERE $228.6 MILLION COMPARED TO $247.9 MILLION AS OF
MARCH 31, 2022
    * PARDES BIOSCIENCES - EXPECTS CASH AND CASH EQUIVALENTS ON
HAND
AS OF JUNE 30, 2022, SUFFICIENT TO FUND EXPENSES, CAPITAL
EXPENDITURES INTO H2 OF 2023
    * PARDES BIOSCIENCES INC - QTRLY NET LOSS PER SHARE, BASIC
AND
DILUTED $0.48

Source text for Eikon:  ID:nGNXbwl2fN 
Further company coverage:  PRDS.O